Latest filing published 27 Aug 2021 for Prelude Therapeutics Inc, €13k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brian Piper: trading record in brief
This profile gathers the share dealings of Brian Piper in Prelude Therapeutics Inc, where the filings describe the role as finance chief. We count 9 filings; the first trade dates from 25 May 2021 and the latest from 25 August 2021.
No open-market purchase appears, only 7 sales worth €469k. Besides market trades, the filings include 2 option exercises.
The record was last updated on 27 August 2021 with an open-market sale (€58k) in Prelude Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Brian Piper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,333 shares@ US$1.8951.0% of flowCommon StockSEC:0001209191-21-053758:0
- 8,333 shares@ US$1.8949.0% of flowCommon StockSEC:0001209191-21-036297:0
2 of 2 declarations
